Dicerna Pharma (DRNA) Tops Q3 EPS by 17c
Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.68), $0.17 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.68), $0.17 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.